VentriPoint Diagnostics Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: 0.146x

VentriPoint Diagnostics Ltd cash flow conversion efficiency. Based on the latest financial reports, VentriPoint Diagnostics Ltd (VPT) has a cash flow conversion efficiency ratio of 0.146x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-599.37K ≈ $-433.58K USD) by net assets (CA$-4.12 Million ≈ $-2.98 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of VentriPoint Diagnostics Ltd (2005–2025)

Cash flow conversion efficiency of VentriPoint Diagnostics Ltd from 2005 to 2025. This chart illustrates how VentriPoint Diagnostics Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest VentriPoint Diagnostics Ltd stock price today for real-time trading data and today's change.

VentriPoint Diagnostics Ltd Cash Flow Conversion Ratio Explained

VentriPoint Diagnostics Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

VentriPoint Diagnostics Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of VentriPoint Diagnostics Ltd ranked by their cash flow conversion efficiency. Also see VPT stock market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Admiralty Resources NL
AU:ADY
0.000x
Pilulka Lekarny as
PR:PINK
N/A
aXichem AB
ST:AXIC-A
-0.034x
TwentyFour Income Fund Ltd
LSE:TFIF
0.015x
Four Leaf Acquisition Corporation Class A Common Stock
NASDAQ:FORL
-0.074x
i2S SA
PA:ALI2S
0.169x
Trailbreaker Resources Ltd
V:TBK
-0.011x
G Capital Bhd
KLSE:7676
0.031x

Annual Cash Flow Conversion Efficiency for VentriPoint Diagnostics Ltd (2005–2025)

The table below shows the annual cash flow conversion efficiency of VentriPoint Diagnostics Ltd from 2005 to 2025. Review cash generation quality of VentriPoint Diagnostics Ltd to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CA$-4.12 Million
≈ $-2.98 Million
CA$-1.55 Million
≈ $-1.12 Million
0.378x -66.74%
2024-12-31 CA$-2.98 Million
≈ $-2.16 Million
CA$-3.39 Million
≈ $-2.45 Million
1.136x +105.66%
2023-12-31 CA$189.71K
≈ $137.23K
CA$-3.80 Million
≈ $-2.75 Million
-20.052x -2107.17%
2022-12-31 CA$4.55 Million
≈ $3.29 Million
CA$-4.14 Million
≈ $-2.99 Million
-0.908x -140.60%
2021-12-31 CA$8.33 Million
≈ $6.03 Million
CA$-3.15 Million
≈ $-2.28 Million
-0.378x -180.59%
2020-12-31 CA$-2.35 Million
≈ $-1.70 Million
CA$-1.10 Million
≈ $-795.98K
0.469x -51.41%
2019-12-31 CA$-2.47 Million
≈ $-1.79 Million
CA$-2.38 Million
≈ $-1.72 Million
0.964x -69.22%
2018-12-31 CA$-973.26K
≈ $-704.04K
CA$-3.05 Million
≈ $-2.21 Million
3.133x +65.95%
2017-12-31 CA$-1.63 Million
≈ $-1.18 Million
CA$-3.07 Million
≈ $-2.22 Million
1.888x +93.11%
2016-12-31 CA$-2.25 Million
≈ $-1.63 Million
CA$-2.20 Million
≈ $-1.59 Million
0.978x -83.62%
2015-12-31 CA$-269.66K
≈ $-195.07K
CA$-1.61 Million
≈ $-1.16 Million
5.967x +1033.35%
2014-12-31 CA$-2.40 Million
≈ $-1.73 Million
CA$-1.26 Million
≈ $-912.31K
0.526x -36.40%
2013-12-31 CA$-3.12 Million
≈ $-2.26 Million
CA$-2.58 Million
≈ $-1.87 Million
0.828x -49.84%
2012-12-31 CA$-2.65 Million
≈ $-1.92 Million
CA$-4.37 Million
≈ $-3.16 Million
1.650x -3.38%
2011-12-31 CA$-2.33 Million
≈ $-1.68 Million
CA$-3.98 Million
≈ $-2.88 Million
1.708x -27.65%
2010-12-31 CA$-860.17K
≈ $-622.24K
CA$-2.03 Million
≈ $-1.47 Million
2.360x +434.52%
2009-12-31 CA$-3.26 Million
≈ $-2.36 Million
CA$-1.44 Million
≈ $-1.04 Million
0.442x -80.32%
2008-12-31 CA$-1.87 Million
≈ $-1.35 Million
CA$-4.20 Million
≈ $-3.04 Million
2.244x +682.50%
2007-12-31 CA$2.50 Million
≈ $1.81 Million
CA$-965.08K
≈ $-698.12K
-0.385x -590.65%
2006-12-31 CA$670.44K
≈ $484.98K
CA$-37.40K
≈ $-27.06K
-0.056x -886.77%
2005-12-31 CA$695.36K
≈ $503.01K
CA$-3.93K
≈ $-2.84K
-0.006x --

About VentriPoint Diagnostics Ltd

V:VPT Canada Medical Devices
Market Cap
$11.16 Million
CA$15.43 Million CAD
Market Cap Rank
#26665 Global
#1078 in Canada
Share Price
CA$0.08
Change (1 day)
+0.00%
52-Week Range
CA$0.08 - CA$0.17
All Time High
CA$0.69
About

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), which transforms standard 2D and 3D echocardiography and a medical imaging system that is used to generate three-dimensional models with critical volume and functional m… Read more